Progressive Multiple Sclerosis Completed Phase 1 Trials for Acyclovir (DB00787)

Back to Progressive Multiple Sclerosis

Also known as: Progressive multiple sclerosis

IndicationStatusPhase
DBCOND0051688 (Progressive Multiple Sclerosis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02282826A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisTreatment
NCT02977533A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisTreatment